Background: Since the outbreak of coronavirus disease 2019 (COVID-19), clinical features have been analyzed in detail. However, coagulopathy in elderly COVID-19 patients has been scarcely reported. Methods: Coagulation parameters of 189 patients with COVID-19 in Tongji hospital were retrospectively analyzed among age groups. Results: Patients were divided into 2 groups: older group (≥65 years, n = 87) and younger group (<65 years, n = 102). The proportion of patients with elevated fibrinogen (79.0% vs 59.6%, p =.005) and D-dimer (78.0% vs 55.2%, p =.001) shows the significant difference between the groups. The elderly patients revealed significantly longer prothrombin time (14.0 [13.4–14.4]s vs 13.6 [13.2–14.1]s, p =.026), higher D-dimer (1.00 [0.5–1.9] μg/mL vs 0.6 [0.3–1.6] μg/mL, p =.013) and fibrinogen (5.2 [4.1–6.2] g/L vs 4.4 [3.4–5.7] g/L, p =.004) levels, compared to the younger group. A positive correlation was observed between the coagulation parameters and inflammatory markers including high-sensitivity C-reactive protein and interleukin-6 (p
CITATION STYLE
Yuan, X., Tong, X., Wang, Y., Wang, H., Wang, L., & Xu, X. (2020). Coagulopathy in elderly patients with coronavirus disease 2019. Aging Medicine, 3(4), 260–265. https://doi.org/10.1002/agm2.12133
Mendeley helps you to discover research relevant for your work.